PMID: 9436179Jan 22, 1998Paper

Review of pharmacodynamics, pharmacokinetics, and therapeutic properties of sulodexide

Medicinal Research Reviews
J Harenberg

Abstract

Due to various side effects of heparin, such as heparin-induced thrombocytopenia type I or type II, alternative anticoagulants are in clinical development to optimize the anticoagulant regimes in patients requiring low or high anticoagulation dosages. Sulodexide is a highly purified preparation containing a fast-moving heparin fraction as well as dermatansulfate. The pharmacological effects of sulodexide differ substantially from unfractionated heparin and are mainly characterized by a prolonged half-life and reduced effect on global coagulation and bleeding parameters. The lipolytic activity of sulodexide is increased in comparison to unfractionated heparin. Clinical studies demonstrate the safety and efficacy of sulodexide. Specially, oral administration leads to fibrinolytic activities in contrast to oral administration of other glycosaminoglycans. Thus, sulodexide releases tissue plasminogen activator and decreases fibrinogen levels as well as HDL and total cholesterol levels and blood viscosity. Clinical efficacy is demonstrated in peripheral arterial disease, cardiovascular events, in postphlebitic syndrome and on albuminuria in nephropathy.

References

Feb 1, 1976·Thrombosis Research·L M Hiebert, L B Jaques
Jan 1, 1992·Current Medical Research and Opinion·M CospiteE Palazzini
Jan 1, 1992·International Journal of Clinical & Laboratory Research·M BarbantiM Babbini
Jun 1, 1992·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·E L Bierman
Jan 1, 1991·Current Medical Research and Opinion·A Castelluccio, E Bologna
Jan 1, 1990·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·G Di Minno, M Mancini
Apr 1, 1989·Diabetologia·T DeckertA Kofoed-Enevoldsen
Jan 1, 1989·Annals of the New York Academy of Sciences·D P ThomasT W Barrowcliffe
Jun 1, 1988·The Biochemical Journal·F RediniW Hornebeck
Jan 1, 1985·The Journal of International Medical Research·C CorsiE Marrapodi
May 1, 1973·Atherosclerosis·G Hornstra, A Vendelmans-Starrenburg
Apr 1, 1984·Thrombosis Research·G AndriuoliM Barbanti
Jun 1, 1980·Thrombosis Research·I ReyersG de Gaetano
Jun 1, 1995·Drugs·M Verstraete, P Zoldhelyi
Jan 1, 1994·Seminars in Thrombosis and Hemostasis·E MarchiE Gattavecchia
Sep 1, 1993·Biochemical Pharmacology·G RajtarC Cerletti
Sep 1, 1996·The Journal of International Medical Research·A GaddiS Nascetti
Sep 1, 1995·Clinical Drug Investigation·G L MessaT Di Perri

❮ Previous
Next ❯

Citations

Mar 9, 2013·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Damien Noone, Christoph Licht
Jan 12, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Michele RossiniAgnes B Fogo
Jan 12, 2007·Cardiovascular Drug Reviews·D Adam Lauver, Benedict R Lucchesi
Dec 14, 2006·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Joanna GoździkiewiczMichal Myśliwiec
Nov 17, 2009·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Jacek BorawskiMichal Mysliwiec
Feb 15, 2012·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Giuseppe Maria Andreozzi
Nov 6, 2018·Journal of Thrombosis and Haemostasis : JTH·B J CarrollS Z Goldhaber
Sep 15, 2004·The Journal of Pharmacology and Experimental Therapeutics·D Adam LauverBenedict R Lucchesi
Jan 2, 2009·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Jacek BorawskiMichal Mysliwiec
Jul 14, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Anneleen PletinckWim Van Biesen
Dec 2, 1999·Angiology·G ScondottoL Martini
Aug 2, 2006·Treatments in Endocrinology·Cataldo Abaterusso, Giovanni Gambaro
Jul 11, 2012·Nature Reviews. Nephrology·Anneleen PletinckWim Van Biesen
Jul 22, 2010·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Jacek BorawskiMichal Mysliwiec
May 20, 2014·Expert Opinion on Emerging Drugs·Sergio StefoniMaria Laura Angelini
May 5, 2012·Acta Pharmacologica Sinica·Ping LiXiang-mei Chen
Aug 26, 2009·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Cafer AdiguzelJawed Fareed
Jan 3, 2021·Clinical Hemorheology and Microcirculation·Sung-Hwa SohnWon-Min Jo
Jun 7, 2011·European Journal of Pharmacology·Heung Yong JinTae Sun Park

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.